Results 71 to 80 of about 172,563,589 (112)
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target. [PDF]
Neurooncol AdvLuning R, Maas SLN, French PJ, Hoogstrate Y, van Hijfte L, Head R, de Heer I, van den Bosch TPP, Woehrer A, van den Bent MJ, Geurts M. +10 moreeuropepmc +1 more sourceBrain atrophy patterns in anti-IgLON5 disease. [PDF]
BrainYogeshwar SM, Bartels F, Grüter T, Muñiz-Castrillo S, Picard G, Crijnen YS, Bernard E, Heidbreder A, Zekeridou A, Ringelstein M, Kraft A, Kovac S, Wandinger KP, de Vries JM, Boon AJW, Veenbergen S, Geis C, Penner L, Melzer N, Leypoldt F, Blaabjerg M, Pittock SJ, Gaig C, Sabater L, Santamaria J, Graus F, Dalmau J, Prüss H, Höftberger R, Schreiner B, McKeon A, Lewerenz J, Irani S, Mignot E, Titulaer MJ, Ayzenberg I, Honnorat J, Finke C, IgLON5 Imaging Consortium
. +38 moreeuropepmc +1 more sourceDeath following high-dose AAV9 gene therapy in a patient with advanced SMA-PME. [PDF]
Mol TherBoespflug-Tanguy O, Valent A, Rambaud J, Léger PL, Plu I, Seilhean D, Frémeaux-Bacchi V, Levade T, Marinello M, Denard J, Derome M, Brun PL, Guerchet N, Veron P, Blatzer M, Fragnoud R, Prieto L, Corbel T, Knuchel-Legendre N, Beaurain B, Lelait M, Sanz M, Abergel K, Rivière A, Buj-Bello A, Perret G. +25 moreeuropepmc +1 more source[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial. [PDF]
J Nucl MedAlbert NL, Tabouret E, Le Rhun E, Sahm F, Furtner J, Tonn JC, Alfano C, Silva JP, Govaerts AS, Gorlia T, Mirante O, Minniti G, Weller M, Preusser M, European Organisation for Research and Treatment of Cancer Brain Tumor Group. +14 moreeuropepmc +1 more sourceNeuronal pSTAT1 hallmarks synaptic pathology in autoimmune encephalitis against intracellular antigens. [PDF]
Acta NeuropatholDi Liberto G, Egervari K, Vogrig A, Spatola M, Piccinno M, Vincenti I, Wagner I, Kreutzfeldt M, Endmayr V, Ostertag K, Rahimi J, Vicino A, Pröbstel AK, Meyronet D, Frank S, Prinz M, Hewer E, Brouland JP, de Leval L, Parkkinen L, Draganski B, Desestret V, Dubey D, Pittock SJ, Roemer SF, Dickson DW, Höftberger R, Irani SR, Honnorat J, Du Pasquier R, Merkler D. +30 moreeuropepmc +1 more source